PT UBC Medical Indonesia Tbk (ISX:LABS) NonCurrent Deferred Liabilities: Rp0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PT UBC Medical Indonesia Tbk NonCurrent Deferred Liabilities?

PT UBC Medical Indonesia Tbk ISX:LABS +1.32% NonCurrent Deferred Liabilities is Rp0.00 Mil as of . 20. The stock has 2 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

PT UBC Medical Indonesia Tbk's non-current deferred liabilities for the quarter that ended in . 20 was Rp0.00 Mil.

PT UBC Medical Indonesia Tbk NonCurrent Deferred Liabilities Related Terms

PT UBC Medical Indonesia Tbk NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for PT UBC Medical Indonesia Tbk's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT UBC Medical Indonesia Tbk NonCurrent Deferred Liabilities Chart

PT UBC Medical Indonesia Tbk Annual Data
Trend
NonCurrent Deferred Liabilities

PT UBC Medical Indonesia Tbk Semi-Annual Data
NonCurrent Deferred Liabilities
What does a NonCurrent Deferred Liabilities of Rp0.00 Mil mean?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a NonCurrent Deferred Liabilities of Rp0.00 Mil as of . 20. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on PT UBC Medical Indonesia Tbk and its competitors.
Is PT UBC Medical Indonesia Tbk's NonCurrent Deferred Liabilities too high?
PT UBC Medical Indonesia Tbk's current NonCurrent Deferred Liabilities is Rp0.00 Mil.
How does PT UBC Medical Indonesia Tbk's NonCurrent Deferred Liabilities compare to ABT and SYK?
PT UBC Medical Indonesia Tbk's NonCurrent Deferred Liabilities of Rp0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Devices & Instruments company?
A good NonCurrent Deferred Liabilities depends on the Medical Devices & Instruments industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on PT UBC Medical Indonesia Tbk and its competitors. PT UBC Medical Indonesia Tbk's current NonCurrent Deferred Liabilities is Rp0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT UBC Medical Indonesia Tbk stock overvalued right now?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a current NonCurrent Deferred Liabilities of Rp0.00 Mil. The current NonCurrent Deferred Liabilities is Rp0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For PT UBC Medical Indonesia Tbk (ISX:LABS), the current NonCurrent Deferred Liabilities is Rp0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT UBC Medical Indonesia Tbk Business Description

Address Jl. Rawagelam V, Blok L, No Kav 11-13, Kantor Pusat, Kawasan Industri Pulogadung, Kel. Jatinegara Kec. Cakung, Jakarta Timur, Jakarta, IDN
PT UBC Medical Indonesia Tbk is a distribution company. It engages in wholesale of Laboratory Equipment, Pharmaceutical Equipment, and Medical Equipment for Humans and animals, which includes the wholesale of laboratory equipment, pharmaceutical equipment, and medical equipment. It divides its main marketed medical equipment products into two categories Instruments, in the form of equipment, machines, and analyzers, are used in laboratories. The function of instruments is to process specimens or biological samples to measure and examine the levels of certain substances/contents; and Consumables include single-use medical devices used for treatment or health examinations and Reagents include chemical reagents used in laboratory tests to detect, measure, examine, & produce other substances.